DYN:NASDAQ
Dyne Therapeutics, Inc
$18.42
arrow_downward
-4.01%(-0.77) 1D
$17.86
arrow_downward
-3.05% (-0.56)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DYN...
Open
$19.02
High
$19.02
Low
$17.93
Mkt. cap
3.44B
Avg. vol.
2.41M
Volume
0.00
52-wk high
$27.30
52-wk low
$11.92
EPS
-$3.33
Beta
1.08
Shares outstanding
186.75M
No. of employees
289
Open
$19.02
High
$19.02
Low
$17.93
Mkt. cap
3.44B
Avg. vol.
2.41M
Volume
0.00
52-wk high
$27.30
52-wk low
$11.92
EPS
-$3.33
Beta
1.08
Shares outstanding
186.75M
No. of employees
289
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
Seeking Alpha
·
1 day ago
Dyne Therapeutics Remains A Buy Even As Novartis Trial Failure Hits DM1 Class (NASDAQ:DYN)
TipRanks
·
1 day ago
Dyne Therapeutics Slumps As Analysts Turn Cautious
About Dyne Therapeutics, Inc
CEO-
Employees289
Founded2017
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitedyne-tx.com